Friday, December 30, 2016 5:04:31 AM
Mr. Robert G. McAllister has been the President at Enertopia Corp. since November 30, 2007 and has been its Chief Executive Officer, Secretary since July 23, 2013. Mr. McAllister has been a Corporate Consultant since 2004. He served as a Treasurer of Enertopia Corp. He served as Investor Relations Professional of Redhawk Resources Inc. He served as Chief Executive Officer of Cheetah Oil & Gas Ltd. from July 29, 2008 to September 19, 2011. He served as Investor Relations Executive at ReMac ZInc. Corp. He has also provided and written business and investment articles from 1996 to 2006 in various North American publications. He is a resource investment entrepreneur with over 20 years experience in resource sector evaluations and commodity cycle analysis. He served as President of Cheetah Oil & Gas Ltd. from July 29, 2008 to May 14, 2010. He served as the Chief Executive Officer of Enertopia Corp. and also served as its Principal Executive Officer until November 30, 2007. Mr. McAllister served as the Chairman of Enertopia Corp. until January 22nd 2016 and has been its Director since April 14, 2008. He served as Interim Chairman of Enertopia Corp. since July 23, 2013. He has been a Member of Advisory Board at Lexaria Bioscience Corp. since March 2014. He served as Director of Cheetah Oil & Gas Ltd. since July 29, 2008 until September 19, 2011.
Recent ENRT News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/01/2024 06:21:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 03:41:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/11/2024 08:38:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 06:24:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 02:01:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 02:02:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 09:09:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 10:06:05 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2023 01:06:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/12/2023 08:29:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 09:24:54 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM